Nations Financial Group Inc, Agenus Inc Transaction History

Nations Financial Group Inc,

  • $1.34 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$1.31 - $2.04 $20 - $32
-16 Reduced 0.11%
15,000 $24,000
Q4 2021

Feb 10, 2022
BUY
$2.92 - $5.74 $13,140 - $25,830
4,500 Added 42.79%
15,016 $48,000
Q3 2021

Nov 12, 2021
BUY
$4.98 - $6.63 $52,369 - $69,721
10,516 New
10,516 $55,000

Others Institutions Holding AGEN

# of Institutions
8
Shares Held
2.07M
Call Options Held
0
Put Options Held
0
View Full List

About AGENUS INC

AGEN Quotes by TradingView
  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Nations Financial Group Inc, Portfolio

Follow Nations Financial Group Inc, and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nations Financial Group Inc, , based on Form 13F filings with the SEC.

News

Stay updated on Nations Financial Group Inc, with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email